Evidence map›Paper›PMID 31009510›Full record

ArticlePloS one2019

Assessment of eight nucleic acid amplification technologies for potential use to detect infectious agents in low-resource settings.

Jason L Cantera, Heather White, Maureen H Diaz, Shivani G Beall, Jonas M Winchell, Lorraine Lillis, Michael Kalnoky, James Gallarda, David S Boyle

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Mimicking anbioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Malaria diagnostic update: From conventional to advanced method.Journal of clinical laboratory analysis · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Detection ofTheScientificWorldJournal · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jason L CanteraPATH, Seattle, Washington, United States of America.
Heather WhitePATH, Seattle, Washington, United States of America.
Maureen H DiazCenters for Disease Control and Prevention, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, Georgia, United States of America.
Shivani G BeallCenters for Disease Control and Prevention, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, Georgia, United States of America.
Jonas M WinchellCenters for Disease Control and Prevention, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, Georgia, United States of America.
Lorraine LillisPATH, Seattle, Washington, United States of America.
Michael KalnokyPATH, Seattle, Washington, United States of America.
James GallardaBill and Melinda Gates Foundation, Seattle, Washington, United States of America.
David S BoylePATH, Seattle, Washington, United States of America.ORCID 0000-0003-4019-9037
Program for Appropriate Technology in Health · USCenters for Disease Control and Prevention · USGates Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid amplification technologies (NAATs) are high-performance tools for rapidly and accurately detecting infectious agents. They are widely used in high-income countries to diagnose disease and improve patient care. The complexities associated with test methods, reagents, equipment, quality control and assurance require dedicated laboratories with trained staff, which can exclude their use in low-resource and decentralized healthcare settings. For certain diseases, fully integrated NAAT devices and assays are available for use in environmentally-controlled clinics or emergency rooms where relatively untrained staff can perform testing. However, decentralized settings in many low- and middle-income countries with large burdens of infectious disease are challenged by extreme environments, poor infrastructure, few trained staff and limited financial resources. Therefore, there is an urgent need for low-cost, integrated NAAT tools specifically designed for use in low-resource settings (LRS). Two essential components of integrated NAAT tools are: 1) efficient nucleic acid extraction technologies for diverse and complex sample types; and 2) robust and sensitive nucleic acid amplification and detection technologies. In prior work we reported the performance and workflow capacity for the nucleic acid extraction component. In the current study we evaluated performance of eight novel nucleic acid amplification and detection technologies from seven developers using blinded panels of RNA and/or DNA from three pathogens to assess both diagnostic accuracy and suitability as an essential component for low-cost NAAT in LRS. In this exercise, we noted significant differences in performance among these technologies and identified those most promising for potential further development.

Indexed as

ChlamydiaCommunicable DiseasesCost-Benefit AnalysisHealth ResourcesHIV-1HumansNeisseria gonorrhoeaeNucleic Acid Amplification TechniquesNucleic AcidsPoint-of-Care SystemsReproducibility of ResultsZika VirusNucleic Acids

Identifiers

PMID31009510
PMCPMC6476514
OpenAlexW2940817401

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.